Genpact legal chief granted 12,471 RSUs

Genpact Limited reported that SVP and Chief Legal Officer Sydney Schaub received an equity award in the form of restricted share units.

Rhea-AI Filing Summary

Genpact Limited reported that SVP and Chief Legal Officer Sydney Schaub received an equity award in the form of restricted share units. On January 30, 2026, Schaub was granted 12,471 common shares at a price of $0, increasing her directly held beneficial ownership to 75,828 common shares.

The award consists of unvested restricted share units granted under the Genpact Limited 2017 Omnibus Incentive Compensation Plan. Each RSU converts into one common share upon vesting. One-third of the RSUs will vest on each of January 10, 2027, January 10, 2028, and January 10, 2029, subject to her continued service through each vesting date.

Insider Trade Summary

Grant/Award: 12,471 shares

Grant/Award 1 txn

Insider Schaub Sydney

Role SVP and Chief Legal Officer

Type	Security	Shares	Price	Value
Grant/Award	Common Shares	12,471	$0.00	$0.00

Holdings After Transaction: Common Shares — 75,828 shares (Direct)

Footnotes (1)

1. F1. Represents an award of unvested restricted share units (RSUs) granted under the Genpact Limited 2017 Omnibus Incentive Compensation Plan. Each RSU entitles the holder to receive one Genpact Limited common share upon vesting. One-third of the shares underlying this RSU award will vest on each of January 10, 2027, January 10, 2028 and January 10, 2029, subject to the reporting person's continued service through each vesting date.

FAQ

What insider transaction did Genpact (G) report for Sydney Schaub?

Genpact reported that SVP and Chief Legal Officer Sydney Schaub received an equity award of 12,471 common shares on January 30, 2026. The award was granted at a price of $0 as restricted share units under the company’s 2017 Omnibus Incentive Compensation Plan.

How many Genpact (G) shares does Sydney Schaub own after this Form 4?

After the reported grant, Sydney Schaub beneficially owns 75,828 Genpact common shares directly. This total reflects the addition of 12,471 shares from the restricted share unit award reported in the Form 4 filed for the January 30, 2026 transaction.

What type of equity award did Genpact (G) grant to Sydney Schaub?

Genpact granted unvested restricted share units (RSUs) to Sydney Schaub under the Genpact Limited 2017 Omnibus Incentive Compensation Plan. Each RSU entitles her to receive one Genpact common share upon vesting, aligning compensation with long-term share ownership.

What is the vesting schedule for Sydney Schaub’s RSU award at Genpact (G)?

The RSU award vests in three equal installments. One-third of the underlying shares will vest on January 10, 2027, another third on January 10, 2028, and the final third on January 10, 2029, contingent on her continued service through each vesting date.

Did Sydney Schaub pay anything for the Genpact (G) RSU grant reported?

The Form 4 shows a transaction price of $0 per share for the 12,471 common shares underlying the RSU grant. This reflects a standard equity compensation award rather than an open-market purchase, consistent with typical executive incentive plan grants.

What is Sydney Schaub’s role at Genpact (G) according to this filing?

According to the filing, Sydney Schaub serves as Senior Vice President and Chief Legal Officer of Genpact Limited. The reported RSU award is part of her executive compensation, granted under the company’s 2017 Omnibus Incentive Compensation Plan for key employees.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 02/03/2026 - 04:03 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Schaub Sydney

(Last) (First) (Middle)

C/O GENPACT LLC

521 FIFTH AVENUE, 14TH FLOOR

(Street)

NEW YORK NY 10175

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Genpact LTD [ G ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	SVP and Chief Legal Officer

3. Date of Earliest Transaction (Month/Day/Year)
01/30/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Shares	01/30/2026		A		12,471(1)	A	$0	75,828	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents an award of unvested restricted share units (RSUs) granted under the Genpact Limited 2017 Omnibus Incentive Compensation Plan. Each RSU entitles the holder to receive one Genpact Limited common share upon vesting. One-third of the shares underlying this RSU award will vest on each of January 10, 2027, January 10, 2028 and January 10, 2029, subject to the reporting person's continued service through each vesting date.

Remarks:

	/s/ Thomas D. Scholtes, as Attorney-in-fact for Sydney Schaub	02/03/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.